Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| SWK Holdings Corporation | SWKH | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 17.25 | 04:29:32 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 17.25 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 15.26 - 18.75 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 17.25 | USD |
SWK Holdings Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 312.45M | 12.50M | - | 44.06M | 15.89M | 1.27 | 19.67 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
SWK News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SWKH Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 17.11 | 17.74 | 17.04 | 17.36 | 6,245 | 0.14 | 0.82% |
| 1 Month | 17.55 | 18.30 | 16.66 | 17.18 | 7,549 | -0.30 | -1.71% |
| 3 Months | 17.50 | 18.488 | 15.92 | 17.19 | 10,949 | -0.25 | -1.43% |
| 6 Months | 15.91 | 18.75 | 15.65 | 17.12 | 9,000 | 1.34 | 8.42% |
| 1 Year | 17.42 | 18.75 | 15.26 | 16.80 | 9,338 | -0.17 | -0.98% |
| 3 Years | 16.73 | 20.4945 | 15.26 | 17.97 | 15,152 | 0.52 | 3.11% |
| 5 Years | 14.00 | 20.4945 | 6.12 | 16.89 | 14,407 | 3.25 | 23.21% |
SWK Description
| SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment. |
